From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Women still struggle to reach leadership positions in pharma. Now that we’ve acknowledged the issue, we can focus on overcoming it.

There are myriad opportunities across different industries for young scientific talent. Why work in the pharma industry?

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.